Cargando…
Identification of a Recombinant Human Interleukin-12 (rhIL-12) Fragment in Non-Reduced SDS-PAGE
During the past two decades, recombinant human interleukin-12 (rhIL-12) has emerged as one of the most potent cytokines in mediating antitumor activity in a variety of preclinical models and clinical studies. Purity is a critical quality attribute (CQA) in the quality control system of rhIL-12. In o...
Autores principales: | Yu, Lei, Li, Yonghong, Tao, Lei, Jia, Chuncui, Yao, Wenrong, Rao, Chunming, Wang, Junzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479496/ https://www.ncbi.nlm.nih.gov/pubmed/30925680 http://dx.doi.org/10.3390/molecules24071210 |
Ejemplares similares
-
Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma
por: Lenzi, Renato, et al.
Publicado: (2007) -
Automation of [(18)F]fluoroacetaldehyde synthesis: application to a recombinant human interleukin‐1 receptor antagonist (rhIL‐1RA)
por: Morris, Olivia, et al.
Publicado: (2016) -
Protein and Signaling Pathway Responses to rhIL-6 Intervention Before Lobaplatin Treatment in Osteosarcoma Cells
por: Wang, Huan, et al.
Publicado: (2021) -
NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacy
por: Miyazaki, Takahiro, et al.
Publicado: (2021) -
Quantitative phosphoproteomic analysis reveals chemoresistance-related proteins and signaling pathways induced by rhIL-6 in human osteosarcoma cells
por: Zhang, Rui, et al.
Publicado: (2021)